KR850008678A - 2-아미노-3-에톡시카보닐아미노-6-cP-플루오로-벤질아미노)-피리딘 글루코노이트의 제조방법 - Google Patents

2-아미노-3-에톡시카보닐아미노-6-cP-플루오로-벤질아미노)-피리딘 글루코노이트의 제조방법 Download PDF

Info

Publication number
KR850008678A
KR850008678A KR1019850003047A KR850003047A KR850008678A KR 850008678 A KR850008678 A KR 850008678A KR 1019850003047 A KR1019850003047 A KR 1019850003047A KR 850003047 A KR850003047 A KR 850003047A KR 850008678 A KR850008678 A KR 850008678A
Authority
KR
South Korea
Prior art keywords
ethoxycarbonylamino
amino
benzylamino
fluoro
preparing
Prior art date
Application number
KR1019850003047A
Other languages
English (en)
Inventor
헤트케(외 2) 헬무트
Original Assignee
게르하르트 노박, 로렌쯔 크로이쯔비흘러
데구사 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게르하르트 노박, 로렌쯔 크로이쯔비흘러, 데구사 아크티엔 게젤샤프트 filed Critical 게르하르트 노박, 로렌쯔 크로이쯔비흘러
Publication of KR850008678A publication Critical patent/KR850008678A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음.

Description

2-아미노-3-에톡시카보닐아미노-6-cP-플루오로-벤질아미노)-피리딘 글루코노이트의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 2-아미노-3-에톡시카보닐아미노-6-(P-플루오로-벤질아미노)-피리딘을 20℃ 내지 140℃의 온도에서, 용매존재 또는 부재하에 글루콘산과 반응시키거나, 용매/물 혼합물중의 글루콘산-△-락톤과 반응시킬을 특징으로하여, 하기 구조식(I)의 2-아미노-3-에톡시카보닐아미노-6-(P-플루오로벤질아미노)-피리딘글루코네이트를 제조하는 방법.
    ※ 참고사항: 최초출원 애용에 의하여 공개하는 것임.
KR1019850003047A 1984-05-05 1985-05-04 2-아미노-3-에톡시카보닐아미노-6-cP-플루오로-벤질아미노)-피리딘 글루코노이트의 제조방법 KR850008678A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3416609.2 1984-05-05
DE19843416609 DE3416609A1 (de) 1984-05-05 1984-05-05 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten

Publications (1)

Publication Number Publication Date
KR850008678A true KR850008678A (ko) 1985-12-21

Family

ID=6235001

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850003047A KR850008678A (ko) 1984-05-05 1985-05-04 2-아미노-3-에톡시카보닐아미노-6-cP-플루오로-벤질아미노)-피리딘 글루코노이트의 제조방법

Country Status (25)

Country Link
US (1) US4673666A (ko)
EP (1) EP0160865B1 (ko)
JP (1) JPS60239469A (ko)
KR (1) KR850008678A (ko)
AT (1) ATE33638T1 (ko)
AU (1) AU4194385A (ko)
BG (1) BG44537A3 (ko)
CA (1) CA1263398A (ko)
CS (1) CS248743B2 (ko)
DD (1) DD236927A5 (ko)
DE (2) DE3416609A1 (ko)
DK (1) DK157016C (ko)
ES (1) ES8603423A1 (ko)
FI (1) FI80443C (ko)
GR (1) GR851065B (ko)
HU (1) HU193753B (ko)
IE (1) IE57766B1 (ko)
IL (1) IL75086A (ko)
MC (1) MC1651A1 (ko)
NO (1) NO851772L (ko)
PL (1) PL253202A1 (ko)
PT (1) PT80386B (ko)
SU (1) SU1398772A3 (ko)
YU (1) YU71785A (ko)
ZA (1) ZA853351B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US8222282B2 (en) 2008-06-09 2012-07-17 Teva Pharmaceuticals Usa, Inc. Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
WO2009152168A2 (en) 2008-06-09 2009-12-17 Awd. Pharma Gmbh & Co. Kg Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
WO2012004391A1 (en) 2010-07-09 2012-01-12 K.H.S. Pharma Holding Gmbh Process for the preparation of flupirtine maleate
CN102850265B (zh) * 2011-06-29 2015-11-25 陈小花 一种氟吡汀偶联物及其制备方法和用途
CN102351786A (zh) * 2011-11-01 2012-02-15 东南大学 一种氟吡汀丙二酸盐及其制备方法
CN103910674B (zh) * 2013-12-19 2015-12-02 天津红日药业股份有限公司 用于马来酸氟吡汀分析中的参比化合物
CN104974087A (zh) * 2015-01-30 2015-10-14 吉林修正药业新药开发有限公司 一种氟吡汀二聚体的合成方法
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133519A1 (de) * 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate

Also Published As

Publication number Publication date
AU4194385A (en) 1985-11-07
CS248743B2 (en) 1987-02-12
FI80443B (fi) 1990-02-28
EP0160865A3 (en) 1986-03-12
NO851772L (no) 1985-11-06
ATE33638T1 (de) 1988-05-15
IL75086A (en) 1988-03-31
DE3416609A1 (de) 1985-11-07
PT80386B (de) 1987-04-16
FI851752L (fi) 1985-11-06
BG44537A3 (en) 1988-12-15
GR851065B (ko) 1985-11-25
YU71785A (en) 1988-02-29
DK157016C (da) 1990-03-26
ES542817A0 (es) 1985-12-16
IE851117L (en) 1985-11-05
CA1263398A (en) 1989-11-28
ES8603423A1 (es) 1985-12-16
MC1651A1 (fr) 1986-04-07
FI80443C (fi) 1990-06-11
DK198785A (da) 1985-11-06
PT80386A (de) 1985-06-01
US4673666A (en) 1987-06-16
HUT37758A (en) 1986-02-28
JPH0144185B2 (ko) 1989-09-26
DK157016B (da) 1989-10-30
DE3562242D1 (en) 1988-05-26
DD236927A5 (de) 1986-06-25
DK198785D0 (da) 1985-05-02
JPS60239469A (ja) 1985-11-28
PL253202A1 (en) 1986-07-15
FI851752A0 (fi) 1985-05-03
EP0160865A2 (de) 1985-11-13
IE57766B1 (en) 1993-03-24
EP0160865B1 (de) 1988-04-20
HU193753B (en) 1987-11-30
ZA853351B (en) 1985-12-24
IL75086A0 (en) 1985-09-29
SU1398772A3 (ru) 1988-05-23

Similar Documents

Publication Publication Date Title
KR850008678A (ko) 2-아미노-3-에톡시카보닐아미노-6-cP-플루오로-벤질아미노)-피리딘 글루코노이트의 제조방법
KR850005452A (ko) 항생물질 화합물의 제조방법
KR860008144A (ko) 1,3- 디알킬 -2- 이미다졸리디논의 제조방법
KR860007214A (ko) 2-아미노-3-니트로-6-(4-플루오로벤질아미노)-피리딘 및 2-아미노-3-카브에톡시아미노-6-(4-플루오로-벤질아미노)- 피리딘의 제조방법
KR840004760A (ko) 셀레늄 유기화합물의 제조방법
KR850001149A (ko) 2-3차-부틸아미노-3'-클로로프로피오페논 말레에이트의 제조방법
KR830006286A (ko) 빈카민 사카리내이트의 제조방법
KR840001530A (ko) 분산제 조성물
KR830009077A (ko) 푸란 유도체의 제조방법
KR840007557A (ko) 모노-니트로 방향족 화합물의 제조방법
KR910007945A (ko) 알킬 메틸-3-카브알콕시에틸포스피네이트의 제조방법
KR890006561A (ko) 디알킬 디클로로숙시네이트의 개선된 제조방법
KR860002473A (ko) 4-메틸-5-티오포름아미디노메틸이미다졸 디하이드로클로라이드의 제조방법
KR840001547A (ko) 항염증작용, 살균작용 및 항균작용을 갖는 화합물의 제조방법
KR840005114A (ko) 아제티딘 술폰산의 제조방법
KR860001059A (ko) 티오우레아 유도체로부터 우레아 유도체의 제조 방법
KR850001228A (ko) (8s)-8-플루오로에리트로마이신의 제조방법
KR840002367A (ko) 3-메틸-3-(4-아세틸아미노펜옥시)-2,4-디옥사벤조-사이클로헥사논-1-의 제조방법
KR890012953A (ko) 1,2-디설폰 화합물의 제조방법
KR920000700A (ko) L-n-(1-메틸-2-아세틸-비닐)-아스파트산의 제조방법
ES457558A1 (es) Procedimiento para la obtencion de aminonitrofenoles.
KR850007253A (ko) d,1-트랜스-소브레롤의 데오필린-7-아세트산 에스테르의 제조방법
KR830001261A (ko) 안트라퀴논 유도체의 제조방법
KR850005413A (ko) 아미노니트로피리딘의 제조방법
KR850007605A (ko) 5-(3카복시-옥소프로폭시)-α,α,4-트리메틸-3-사이클로 헥센-1-메탄올산의 에리스로 마이신염의 제조방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid